Review: Khayelitsha 2001 - 2011: 10 years of primary care HIV and TB programmes

Tuberculosis (TB) and HIV care in Khayelitsha, and in South Africa as a whole, has overcome numerous obstacles in the past three decades. This article highlights what has been achieved in Khayelitsha, describes the key clinical programme and policy changes that have supported universal coverage for HIV and TB care over the last 10 years, and outlines the challenges for the next decade

The case for Option B and Optional B+: Ensuring that South Africa’s commitment to eliminating mother-to-child transmission of HIV becomes a reality

In a previous issue of the Southern African Journal of HIV Medicine, Pillay and Black summarised the trade-offs of the safety of efavirenz use in pregnancy (Pillay P, Black V. Safety, strength and simplicity of efavirenz in pregnancy. Southern African Journal of HIV Medicine 2012;13(1):28-33.). Highlighting the benefits of the World Health Organization’s proposed options for the prevention of mother-to-child transmission (PMTCT) of HIV, the authors argued that the South African government should adopt Option B as national PMTCT policy and pilot projects implementing Option B+ as a means of assessing the individual- and population-level effect of the intervention. We echo this call and further propose that the option to remain on lifelong antiretroviral therapy, effectively adopting PMTCT Option B+, be offered to pregnant women following the cessation of breastfeeding, for their own health, following the provision of counselling on associated benefits and risks. Here we highlight the benefits of Options B and B+

The Competition Commission Health Market Inquiry Report: An overview and key imperatives

The Competition Commission’s Health Market Inquiry (HMI) is the most systematic and comprehensive investigation carried out into the South African private health sector. The recommendations as set out in the HMI Final Report merit extensive discussion and debate, as they could – if implemented – have far-reaching consequences for the future of the healthcare system. The objective of this article is to contribute to this discussion by providing an overview of the key findings and recommendations of the HMI and highlighting the resultant key imperatives at this critical juncture of policy development

Tratamiento del compromiso femoropatelar mediante la transposición de la tuberosidad tibial anterior según la técnica de Maquet II

Se presentan 50 rodillas en un total de 40 pacientes intervenidos entre los años 1983 y 1990 con la técnica de Maquet II por presentar compromiso femoropatelar. El objetivo de este trabajo ha sido la valoración de la evolución de los resultados a lo largo del tiempo. La edad media de los pacientes ha sido de 48 años, con un seguimiento medio de 8 años y 4 meses. La patología femoropatelar se ha dividido en 2 grupos: artrosis y condromalacia avanzada. El injerto óseo utilizado ha sido autólogo en el 30% de los casos y heterólogo de banco en los restantes, con un adelantamiento medio de la tuberosidad tibial anterior (TTA) de 11 mm. La valoración de resultados se realizó teniendo en cuenta parámetros clínicos y radiográficos, realizando una primera valoración en junio de 1992 y otra en marzo de 1996. Los resultados globales han sido de un 68% de resultados muy buenos y buenos, 22% regulares y 10% malos, apreciándose un escaso deterioro de los mismos entre las 2 revisiones. Se concluye que la técnica es válida para este tipo de patología, siendo suficiente el adelantamiento de la TTA de 10 mm.We present 50 knees in 40 patients who were operated between 1983 and 1990 with Maquet II procedure because of patellofemoral pathology. The purpose of this work was the long-term evaluation of results. The average age of the patients was 48 years with a mean followup of 8 years and 4 months. The patellofemoral pathology was divided in 2 groups: osteoarthrosis and advanced chondromalacia. The bone graft employed was autologous graft in 30% cases and heterologous graft in the others, with an average anterior displacement of the anterior tibial tuberosity of 11 mm. The evaluation of the results was done based on clinical and radiographical parameters. The final outcome was found to be 68% of very good and good results, 22% fair and 10% bad results. An slight impairement was observed along the period of study. The conclusion is that this procedure is valid for this pathology, being enough an anterior displacement of the tibial tuberosity of 10 mm

Central nervous system manganese induced lesions and clinical consequences in patients with hereditary hemorrhagic telangiectasia

Abstract Background Around 47–74% of patients with hereditary hemorrhagic telangiectasia (HHT) have hepatic vascular malformations (HVMs); magnetic resonance images (MRI) of the central nervous system (CNS) might show in T1 sequences a hyper-intensity signal in different areas, mainly in the basal ganglia (BG) as consequence of manganese (Mn) deposits as observed in cirrhotic patients. These patients might suffer from different neuropsychiatric disorders (hepatic encephalopathy). In HHT patients, even in the presence of hepatic shunts, hepatocellular function is usually preserved. Additionally, Mn shares iron absorption mechanisms, transferrin and CNS transferrin receptors. In iron deficiency conditions, the Mn may harbor transferrin and access BG. The objectives were to describe frequency of BG Mn deposit-induced lesions (BGMnIL) in HHT patients, its relationship with iron deficiency anemia (IDA) and HVMs. Finally, explore the association between neuropsychological and motor consequences. We performed a cross-sectional study. We determined HHT patients with or without BG-MnIL by the MRI screening of the CNS. We included all patients with lesions and a random sample of those without lesions. All patients underwent standardized and validated neuropsychological assessment to evaluate BG actions. Results were analyzed with multiple logistic regression, adjusting for potential confounders. Results Among 307 participants from a cohort included in the Institutional HHT Registry, 179 patients had MRI performed and Curaçao Criteria ≥3. The prevalence of BG-MnIL was 34.6% (95%CI 27.69-42.09). While neuropsychological symptoms were present in all patients, BG-MnIL patients performed poorly in three of the neuropsychological tests (serial dotting, line tracing time, number connection test A). HVMs frequency in BG-MnIL was 95.1%, versus 71.4% in those without lesions (p < 0.001). IDA frequency was 90.3% versus 54% (p < 0.001). When IDA is present, estimated risk for BG-MnIL is remarkably high (OR 7.73, 95%CI 2.23–26.73). After adjustment for possible confounders (gender, age, presence of HVMs), IDA was still associated with increased risk of BG-MnIL (adjusted OR 6.32, 95% CI 2.32–17.20; p < 0.001). Conclusions Physicians should assess BG-MnIL in HHT patients in CNS-MRI. IDA and HVMs present increased risk of lesions. Patients with BG-MnIL have neuropsychological impairment, and they might benefit from sparing IDA, or undergoing future therapeutic options. Trial registration NCT01761981 . Registered January 3rd 2013

Compuestos orgánicos en aguas del estuario del Río Miño. Proyecto "TEAM-Miño"

Comunicación presentada al II Congreso Internacional de Ingeniería Civil y Territorio. Agua, Cultura y Sociedad. Vigo, 20 y 21 de Mayo de 2013.Los resultados de este trabajo se engloban en el Marco del proyecto TEAM-Miño “Transferencia de herramientas para la Evaluación, Ordenación, Gestión y Educación Ambiental en Estuarios” financiado por la Unión Europea (POCTEP 2007-2013), que pretende desarrollar herramientas comunes para la tipificación y clasificación del estado ecológico de las masas de agua de transición del sur de Galicia y norte de Portugal, con la finalidad de colaborar en la implantación de la Directiva Marco del Agua. Se han analizado 19 muestras de agua recogidas a lo largo del río Miño y sus afluentes. En ellas se han determinado diferentes contaminantes de amplio interés industrial y ambiental, como hidrocarburos aromáticos policíclicos (HAP), compuestos organoestánnicos, alquilfenoles y bisfenol A. Salvo excepciones, los niveles encontrados en las muestras no son elevados (<0,1 μg/L). La mayoría de los HAPs se encuentran por debajo de los límites de cuantificación del método analítico (MQL), siendo el compuesto mayoritario el naftaleno. Los compuestos organoestánnicos tampoco han sido detectados. Los alquilfenoles están presentes en todos los puntos muestreados (<MQL-1 μg/L), mientras que el bisfenol A se ha encontrado únicamente en dos de ellos, pero a altas concentraciones (>3 μg/L). En ningún caso las concentraciones medidas superan los límites establecidos en la Directiva 2008/105/CE

Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration

The renin-angiotensin system (RAS) was initially considered as a circulating humoral system controlling blood pressure, being kidney the key control organ. In addition to the \u27classical\u27 humoral RAS, a second level in RAS, local or tissular RAS, has been identified in a variety of tissues, in which local RAS play a key role in degenerative and aging-related diseases. The local brain RAS plays a major role in brain function and neurodegeneration. It is normally assumed that the effects are mediated by the cell-surface-specific G-protein-coupled angiotensin type 1 and 2 receptors (AT1 and AT2). A combination of in vivo (rats, wild-type mice and knockout mice) and in vitro (primary mesencephalic cultures, dopaminergic neuron cell line cultures) experimental approaches (confocal microscopy, electron microscopy, laser capture microdissection, transfection of fluorescent-tagged receptors, treatments with fluorescent angiotensin, western blot, polymerase chain reaction, HPLC, mitochondrial respirometry and other functional assays) were used in the present study. We report the discovery of AT1 and AT2 receptors in brain mitochondria, particularly mitochondria of dopaminergic neurons. Activation of AT1 receptors in mitochondria regulates superoxide production, via Nox4, and increases respiration. Mitochondrial AT2 receptors are much more abundant and increase after treatment of cells with oxidative stress inducers, and produce, via nitric oxide, a decrease in mitochondrial respiration. Mitochondria from the nigral region of aged rats displayed altered expression of AT1 and AT2 receptors. AT2-mediated regulation of mitochondrial respiration represents an unrecognized primary line of defence against oxidative stress, which may be particularly important in neurons with increased levels of oxidative stress such as dopaminergic neurons. Altered expression of AT1 and AT2 receptors with aging may induce mitochondrial dysfunction, the main risk factor for neurodegeneratio